Analysts see strong opposition to the $29B merger of Express Scripts (ESRX) and Medco (MHS),...

|About: Express Scripts, Inc. (ESRX)|By:, SA News Editor

Analysts see strong opposition to the $29B merger of Express Scripts (ESRX) and Medco (MHS), which would leave the industry with just one other independent company, CVS. “It’s going to be a very tough fight through the Federal Trade Commission,” industry consultant Adam Fein says, expecting pharmacists and drug makers to try to block the deal.